# Citizens Community Bancorp Inc.: financial statements, quarterly

CZWI · Nasdaq · CIK 1367859 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/czwi.md) · [Financials](/companies/czwi/financials.md) · [Filings](/companies/czwi/filings.md) · [Insiders](/companies/czwi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/czwi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [9.7](/filings/0001367859-23-000145.md) | [10.3 d](/filings/0001367859-24-000046.md) | [10.8](/filings/0001367859-24-000066.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.5](/filings/0001367859-24-000112.md) | [1.0 d](/filings/0001367859-25-000033.md) | [1.1](/filings/0001367859-25-000052.md) | [1.0](/filings/0001367859-25-000074.md) | [0.9](/filings/0001367859-25-000088.md) | [0.7 d](/filings/0001367859-26-000017.md) | [0.8](/filings/0001367859-26-000034.md) | [0.8](/filings/0001367859-26-000050.md) | [0.9](/filings/0001367859-25-000088.md) | [0.6 d](/filings/0001367859-26-000017.md) | [0.9](/filings/0001367859-26-000034.md) | [0.1](/filings/0001367859-26-000050.md) |
| Net income | $m | [2.5](/filings/0001367859-24-000112.md) | [3.7](/filings/0001367859-24-000112.md) | [4.1](/filings/0001367859-25-000088.md) | [3.7](/filings/0001367859-25-000088.md) | [3.3](/filings/0001367859-25-000088.md) | [2.7](/filings/0001367859-25-000088.md) | [3.2](/filings/0001367859-26-000050.md) | [3.3](/filings/0001367859-26-000050.md) | [3.7](/filings/0001367859-26-000050.md) | [4.3](/filings/0001367859-26-000050.md) | [3.8](/filings/0001367859-26-000050.md) | [1.1](/filings/0001367859-26-000050.md) |
| Diluted EPS | $ per share | [0.24](/filings/0001367859-24-000112.md) | not reported | [0.39](/filings/0001367859-25-000052.md) | [0.35](/filings/0001367859-25-000074.md) | [0.32](/filings/0001367859-25-000088.md) | not reported | [0.32](/filings/0001367859-26-000034.md) | [0.33](/filings/0001367859-26-000050.md) | [0.37](/filings/0001367859-25-000088.md) | not reported | [0.39](/filings/0001367859-26-000034.md) | [0.11](/filings/0001367859-26-000050.md) |
| Basic EPS | $ per share | [0.24](/filings/0001367859-24-000112.md) | not reported | [0.39](/filings/0001367859-25-000052.md) | [0.35](/filings/0001367859-25-000074.md) | [0.32](/filings/0001367859-25-000088.md) | not reported | [0.32](/filings/0001367859-26-000034.md) | [0.33](/filings/0001367859-26-000050.md) | [0.37](/filings/0001367859-25-000088.md) | not reported | [0.39](/filings/0001367859-26-000034.md) | [0.11](/filings/0001367859-26-000050.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.5](/filings/0001367859-23-000145.md) | [37.1](/filings/0001367859-25-000033.md) | [28.6](/filings/0001367859-24-000066.md) | [36.9](/filings/0001367859-24-000084.md) | [36.6](/filings/0001367859-24-000112.md) | [50.2](/filings/0001367859-26-000017.md) | [100](/filings/0001367859-25-000052.md) | [67.5](/filings/0001367859-25-000074.md) | [82.4](/filings/0001367859-25-000088.md) | [119](/filings/0001367859-26-000050.md) | [149](/filings/0001367859-26-000034.md) | [122](/filings/0001367859-26-000050.md) |
| Total assets | $m | [1,831](/filings/0001367859-23-000145.md) | [1,851](/filings/0001367859-25-000033.md) | [1,819](/filings/0001367859-24-000066.md) | [1,802](/filings/0001367859-24-000084.md) | [1,799](/filings/0001367859-24-000112.md) | [1,749](/filings/0001367859-26-000017.md) | [1,780](/filings/0001367859-25-000052.md) | [1,735](/filings/0001367859-25-000074.md) | [1,727](/filings/0001367859-25-000088.md) | [1,782](/filings/0001367859-26-000050.md) | [1,823](/filings/0001367859-26-000034.md) | [1,814](/filings/0001367859-26-000050.md) |
| Total liabilities | $m | [1,666](/filings/0001367859-23-000145.md) | [1,678](/filings/0001367859-25-000033.md) | [1,646](/filings/0001367859-24-000066.md) | [1,626](/filings/0001367859-24-000084.md) | [1,619](/filings/0001367859-24-000112.md) | [1,569](/filings/0001367859-26-000017.md) | [1,600](/filings/0001367859-25-000052.md) | [1,552](/filings/0001367859-25-000074.md) | [1,540](/filings/0001367859-25-000088.md) | [1,594](/filings/0001367859-26-000050.md) | [1,632](/filings/0001367859-26-000034.md) | [1,623](/filings/0001367859-26-000050.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [66.6](/filings/0001367859-26-000017.md) | not reported | not reported | not reported | [51.8](/filings/0001367859-26-000050.md) | [51.8](/filings/0001367859-26-000034.md) | [51.9](/filings/0001367859-26-000050.md) |
| Shareholders' equity | $m | [165](/filings/0001367859-24-000112.md) | [173](/filings/0001367859-26-000017.md) | [173](/filings/0001367859-25-000088.md) | [176](/filings/0001367859-25-000088.md) | [180](/filings/0001367859-25-000088.md) | [179](/filings/0001367859-26-000050.md) | [180](/filings/0001367859-26-000050.md) | [183](/filings/0001367859-26-000050.md) | [187](/filings/0001367859-26-000050.md) | [188](/filings/0001367859-26-000050.md) | [191](/filings/0001367859-26-000050.md) | [191](/filings/0001367859-26-000050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [4,820 d](/filings/0001367859-24-000112.md) | [3,952 d](/filings/0001367859-25-000033.md) | [9,148](/filings/0001367859-25-000052.md) | [5,122 d](/filings/0001367859-25-000074.md) | [3,505 d](/filings/0001367859-25-000088.md) | [2,625 d](/filings/0001367859-26-000017.md) | [1,613](/filings/0001367859-26-000034.md) | [(406) d](/filings/0001367859-26-000050.md) | [6,631 d](/filings/0001367859-25-000088.md) | [3,855 d](/filings/0001367859-26-000017.md) | [3,976](/filings/0001367859-26-000034.md) | [7,914 d](/filings/0001367859-26-000050.md) |
| Capital expenditure | $k | [224 d](/filings/0001367859-24-000112.md) | [596 d](/filings/0001367859-25-000033.md) | [214](/filings/0001367859-25-000052.md) | [313 d](/filings/0001367859-25-000074.md) | [122 d](/filings/0001367859-25-000088.md) | [240 d](/filings/0001367859-26-000017.md) | [100](/filings/0001367859-26-000034.md) | [226 d](/filings/0001367859-26-000050.md) | [392 d](/filings/0001367859-25-000088.md) | [593 d](/filings/0001367859-26-000017.md) | [570](/filings/0001367859-26-000034.md) | [1,475 d](/filings/0001367859-26-000050.md) |
| Dividends paid | $k | [0.0 d](/filings/0001367859-24-000112.md) | [0.0 d](/filings/0001367859-25-000033.md) | [3,346](/filings/0001367859-25-000052.md) | [0.0 d](/filings/0001367859-25-000074.md) | [0.0 d](/filings/0001367859-25-000088.md) | [0.0 d](/filings/0001367859-26-000017.md) | [3,598](/filings/0001367859-26-000034.md) | [0.0 d](/filings/0001367859-26-000050.md) | [0.0 d](/filings/0001367859-25-000088.md) | [0.0 d](/filings/0001367859-26-000017.md) | [1,011](/filings/0001367859-26-000034.md) | [1,013 d](/filings/0001367859-26-000050.md) |
| Share repurchases | $k | [0.0 d](/filings/0001367859-24-000112.md) | [304 d](/filings/0001367859-25-000033.md) | [598](/filings/0001367859-25-000052.md) | [1,236 d](/filings/0001367859-25-000074.md) | [2,893 d](/filings/0001367859-25-000088.md) | [1,370 d](/filings/0001367859-26-000017.md) | [0.0](/filings/0001367859-25-000052.md) | [0.0 d](/filings/0001367859-26-000050.md) | [2,019 d](/filings/0001367859-25-000088.md) | [4,036 d](/filings/0001367859-26-000017.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.5](/filings/0001367859-23-000145.md) | [10.5](/filings/0001367859-24-000066.md) | [10.5](/filings/0001367859-24-000084.md) | [10.5](/filings/0001367859-24-000112.md) | [10.4](/filings/0001367859-25-000052.md) | [10.4](/filings/0001367859-25-000074.md) | [10.2](/filings/0001367859-25-000088.md) | [10.0](/filings/0001367859-26-000034.md) | [10.0](/filings/0001367859-26-000050.md) | [9.9](/filings/0001367859-25-000088.md) | [9.6](/filings/0001367859-26-000034.md) | [9.6](/filings/0001367859-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,650,231 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001367859-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.